CoChat

Coupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT Prolongation

Open access
Lorberbaum, Tal, Sampson, Kevin J., Chang, Jeremy B., Iyer, Vivek, Woosley, Raymond L., Kass, Robert S., Tatonetti, Nicholas P. · 2016 · Journal of the American College of Cardiology
Cited by 78

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background QT-interval prolonging drug-drug interactions (QT-DDIs) may increase the risk of life-threatening arrhythmias. Despite guidelines for testing from regulatory agencies, these interactions are usually discovered after drugs are marketed and may go undiscovered for years. Objectives Using a combination of adverse event reports, electronic health records (EHR), and laboratory experiments, we sought to develop a data-driven pipeline for discovering QT-DDIs. Methods We mined 1.8 million adverse event reports for signals indicating a QT-DDI. Using 1.6 million electrocardiogram results from 380,000 patients in our institutional EHR, we either refuted or corroborated these putative interactions. In the laboratory, we used patch-clamp electrophysiology to measure the human Ether-à-go-go-Related Gene (hERG) block (the primary mechanism by which drugs prolong the QT interval) to evaluate our top candidate. Results We found both direct and indirect signals in the adverse event reports that the combination of ceftriaxone (a cephalosporin antibiotic) and lansoprazole (a proton-pump inhibitor) will prolong the QT interval. In the EHR, we found that patients on both ceftriaxone and lansoprazole had significantly longer QTc intervals (up to 12 ms in white men), and were 1.4 times more likely to have a QTc interval above 500 ms. In the laboratory, we found that these drugs block the hERG channel in combination at clinically-relevant concentrations. As a negative control, we evaluated the combination of lansoprazole and cefuroxime (another cephalosporin), which lacked evidence of an interaction in the adverse event reports. We found no significant effect of this pair in either the EHR or in the electrophysiology experiments. Class effect analyses suggest this interaction is specific to lansoprazole combined with ceftriaxone, but not with other cephalosporins. Conclusions Coupling data mining and laboratory experiments is an efficient method for identifying QT-DDIs. Combination therapy of ceftriaxone and lansoprazole is associated with increased risk of acquired long QT syndrome

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2016.07.761

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 78

Metadata

Authors
Lorberbaum, T., Sampson, K. J., Chang, J. B., Iyer, V., Woosley, R. L., Kass, R. S., & Tatonetti, N. P.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2016-10
Volume
68
Issue
16
Pages
1756-1764
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2530398232
Cited by
78
References
6
FWCI
5.98
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Coupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT Prolongation. https://app.cochat.ai/papers/10.1016/j.jacc.2016.07.761
The paper
Lorberbaum, T., Sampson, K. J., Chang, J. B., Iyer, V., Woosley, R. L., Kass, R. S., & Tatonetti, N. P. (2016). Coupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT Prolongation. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2016.07.761

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.